Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$2.52 USD
+0.01 (0.40%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $2.57 +0.05 (1.98%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ADVM 2.52 +0.01(0.40%)
Will ADVM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADVM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADVM
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Tops Revenue Estimates
Adverum Biotechnologies (ADVM) Upgraded to Strong Buy: What Does It Mean for the Stock?
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
Bet on 5 Top-Ranked Stocks With Rising P/E
Wall Street Analysts See a 332.28% Upside in Adverum Biotechnologies (ADVM): Can the Stock Really Move This High?
Other News for ADVM
Adverum Biotechnologies (ADVM) Price Target Reduced by Mizuho | ADVM Stock News
Adverum Biotechnologies (ADVM) Price Target Reduced by Mizuho | ADVM Stock News
Adverum Biotechnologies price target lowered to $12 from $16 at Mizuho
Adverum Biotechnologies price target lowered by $4 at Mizuho, here's why
Mizuho Securities Sticks to Their Buy Rating for Adverum Biotechnologies (ADVM)